JPY 366.0
(2.56%)
Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Operating Cash Flow | -54.3 Million | 216.64 Million | 805.46 Million | 187.54 Million | 398.19 Million |
Net Income | 103 Million | 921.35 Million | 675.76 Million | 392.01 Million | 170.5 Million |
Depreciation & Amortization | 357.09 Million | 410.89 Million | 304.35 Million | 239.22 Million | 183.06 Million |
Deferred income taxes | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - |
Change in working capital | -288.72 Million | 164.71 Million | -56.72 Million | -387.91 Million | 32.5 Million |
Other non-cash items | -31.12 Million | -48.87 Million | 78.42 Million | 99.71 Million | 393.28 Million |
Investing Cash Flow | -2.12 Billion | 1 Billion | -1.09 Billion | -650.43 Million | -401.65 Million |
Investments in PPE | -621.94 Million | -968.75 Million | -537.03 Million | -669.63 Million | -364.2 Million |
Acquisitions | -699.63 Million | 2.19 Billion | 191 Thousand | 57 Thousand | 1.58 Million |
Investment purchases | -615.94 Million | -13.8 Million | -58.21 Million | -52.4 Million | -113.81 Million |
Sales/Maturities of investments | 200 Million | - | - | 164.79 Million | 220.1 Million |
Other Investing Activities | -383.23 Million | -202 Million | -511.55 Million | -94.24 Million | -145.33 Million |
Financing Cash Flow | 1.08 Billion | -1.02 Billion | 900.1 Million | 675.73 Million | 653.33 Million |
Debt repayment | -1.4 Billion | -895.86 Million | -253.4 Million | -5.05 Million | -653.33 Million |
Dividends payments | -103.08 Million | -102.33 Million | - | - | - |
Common Stock Repurchased | -182.18 Million | - | -109 Thousand | - | - |
Common Stock Issuance | - | 994 Thousand | 653.04 Million | 675.36 Million | - |
Other Financing Activities | 734 Thousand | 2.59 Million | -1000.00 | 6.14 Million | - |
Accounts receivables | -310 Million | -112 Million | 120.33 Million | -416.64 Million | -159.68 Million |
Accounts payables | 250.29 Million | -38.51 Million | -168.75 Million | 91.88 Million | 122.9 Million |
Inventory | -19.95 Million | -2.94 Million | - | - | 21.73 Million |
Other working capital | -252 Million | 219 Million | 25.77 Million | -5.98 Million | 47.54 Million |
Cash at beginning of period | 3.21 Billion | 3.01 Billion | 2.4 Billion | 2.18 Billion | 1.53 Billion |
Cash at end of period | 2.12 Billion | 3.21 Billion | 3.01 Billion | 2.4 Billion | -36 Thousand |
Capital Expenditure | -621.94 Million | -968.75 Million | -537.03 Million | -669.63 Million | -364.2 Million |
Effect of forex changes on cash | - | - | - | - | -36 Thousand |
Net cash flow / Change in cash | -1.08 Billion | 201.26 Million | 611.96 Million | 212.84 Million | -1.53 Billion |
Free Cash Flow | -676.24 Million | -752.11 Million | 268.43 Million | -482.09 Million | 33.99 Million |
Breakdown | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 38 Million | -144 Million | 103 Million | 78 Million | 74 Million | 41 Million |
Depreciation & Amortization | - | - | 357.09 Million | - | - | - |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | - | - | -288.72 Million | - | - | - |
Other non-cash items | -38 Million | 144 Million | -31.12 Million | -78 Million | -74 Million | -41 Million |
Investing Cash Flow | - | - | -2.12 Billion | - | - | - |
Investments in PPE | - | - | -621.94 Million | - | - | - |
Acquisitions | - | - | -699.63 Million | - | - | - |
Investment purchases | - | - | -615.94 Million | - | - | - |
Sales/Maturities of investments | - | - | 200 Million | - | - | - |
Other Investing Activities | - | - | -383.23 Million | - | - | - |
Financing Cash Flow | - | - | 1.08 Billion | - | - | - |
Debt repayment | - | - | -1.4 Billion | - | - | - |
Dividends payments | - | - | -103.08 Million | - | - | - |
Common Stock Repurchased | - | - | -182.18 Million | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | - | - | 734 Thousand | - | - | - |
Accounts receivables | - | - | -310 Million | - | - | - |
Accounts payables | - | - | 250.29 Million | - | - | - |
Inventory | - | - | -19.95 Million | - | - | - |
Other working capital | - | - | -252 Million | - | - | - |
Cash at beginning of period | - | - | 3.21 Billion | - | - | - |
Cash at end of period | - | - | 2.12 Billion | - | - | - |
Capital Expenditure | - | - | -621.94 Million | - | - | - |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | - | - | -1.08 Billion | - | - | - |
Free Cash Flow | - | - | -676.24 Million | - | - | - |
319660
SRE
025540
ACGX
BELYS
SHREERAMA